Results of novel strategies for treatment of Wilm's tumor

International Braz J Urol

Volumn 33, Issue 2, 2007, Pages 195-201

  Tucci Jr , Silvio ^a   Cologna, Adauto J ^a   Suaid, Haylton J ^a   Valera, Elvis T ^a   Tirapelli, Luis F ^a   Paschoalin, Edson L ^a   Martins, Antonio C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemotherapy; Relapse; Surgery; Wilms' tumor

Indexed keywords

EID: 34249780862     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/s1677-55382007000200011     Document Type: Article

References (19)

1. Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grandy P, et al.: Management of Wilms' tumour: current practice and future goals. Lancet Oncol. 2004; 5: 37-46.
2. Pritchard-Jones K, Kelsey A, Vujanic G, Imeson J, Hutton C, Mitchell C, et al.: Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group. J Clin Oncol. 2003; 21: 3269-75.
3. D'Angio GJ, Breslow N, Beckwith JB, Evans A, Baum H, deLorimier A, et al.: Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989; 64: 349-60.
4. de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, et al.: Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet. 2004; 364: 1229-35.
5. Grundy P, Breslow N, Green DM, Sharples K, Evans A, D'Angio GJ: Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms'Tumor Study. J Clin Oncol, 1989; 7:638-47.
6. Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, et al.: Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol. 2002; 24: 192-8.
7. Weirich A, Ludwig R, Graf N, Abel U, Leuschner I, Vujanic GM, et al.: Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004; 15: 808-20.
8. Garaventa A, Hartmann 0, Bernard JL, Zucker JM, Pardo N, Castel V, et al.: Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol. 1994; 22:11-4.
9. Pein F, Michon J, Valteau-Couanet D, Quintana E, Frappaz D, Vannier JP, et al.: High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-fisk recurrent Wilms' tumor: a French Society of Pediatric Oncology study. J Clin Oncol. 1998; 16:3295-301.
10. Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G, et al.: Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital. J Clin Oncol. 2004; 22: 2885-90.
11. Bonadio JF, Storer B, Norkool P, Farewell VT, Beckwith JB, D'Angio GJ: Anaplastic Wihns'tumor: clinical and pathologic studies, J Clin Oncol. 1985; 3: 5 0-20.
12. de Camargo B, Franco EL: A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Results after extended follow-up. Brazilian Wilms' Tumor Study Group. Cancer. 1994; 73: 3081-6.
13. Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy P, Thomas PR, et al.: Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1998; 16: 3744-5 1.
14. Pianezza ML, Rubin S, Bass J, Chou S, Pike JG, Leonard MP: Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001. Can J Urol. 2004; 11: 2151-6.
15. Green DM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, et al.: Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 200 1; 19: 3719-24.
16. Grundy P, Perlman E, Rosen NS, Warwick AB, Bender JG, Ehrlich P, et al.: Current issues in Wilms tumor management. Curr Probl Cancer. 2005; 29: 221-60.
17. Ehrlich PF, Ritchey ML, Hamilton TE, Haase GM, Ou S, Breslow N, et al.: Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5. J Pediatr Surg. 2005; 40: 208-12.
18. Seseke F, Zoller G, Ringert RH: Wilms' tumor-single-center experience with renal surgery. Scand J Urol Nephrol. 2004; 39: 373-7.
19. Ritchey ML, Shamberger RC, Haase G, Horwitz J, Bergemann T, Breslow NE: Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group. J Am Coll Surg. 2001; 192:63-8.